Protheragen Inc Stony Brook, NY - 11790

Protheragen Inc is categorized under Research and Development Laboratories in Stony Brook, NY and active since 2009.

Protheragen Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Donghai Chen at the company’s single location by writing to 1360 Stony Brook Road, Stony Brook, New York NY 11790 or by phoning (516) 765-9461. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Protheragen Inc
Contact Person: Donghai Chen
Address: 1360 Stony Brook Road, Stony Brook, New York 11790
Phone Number: (516) 765-9461
Website Address: protheragen.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Protheragen Inc was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Donghai Chen for inquiries that concern Protheragen Inc by calling the company number (516) 765-9461, as your correspondence is most welcome. Additionally, the physical location of the single location of Protheragen Inc can be found at the coordinates 40.882746,-73.121645 as well as the street address 1360 Stony Brook Road in Stony Brook, New York 11790.

For its online presence, you may visit Protheragen Inc’s website at protheragen.com and engage with its social media outlets through on Twitter and on Facebook.